# A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer

> **NCT06939595** · PHASE3 · RECRUITING · sponsor: **Celltrion** · enrollment: 606 (estimated)

## Conditions studied

- Non Squamous Non Small Cell Lung Cancer

## Interventions

- **DRUG:** CT-P51
- **DRUG:** EU-approved Keytruda

## Key facts

- **NCT ID:** NCT06939595
- **Lead sponsor:** Celltrion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2027-02
- **Final completion:** 2028-07
- **Target enrollment:** 606 (ESTIMATED)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06939595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06939595, "A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06939595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*